D models of uveal melanoma are transforming cancer research, enabling personalized treatments and better drug testing for ...

Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in ...

The summer of 2023 saw the approval of a new treatment option for certain patients with uveal melanoma, a form of cancer that begins in the eye and remains a challenge to treat. Richard Staines ...

After a Stage 4 cancer diagnosis and a prognosis of 16 months to live, Katie Doble didn’t know whether she should plan her ...

Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in ...

Delcath Systems markets Hepzato Kit for the treatment of uveal melanoma with unresectable hepatic metastases. Click here to read my analysis of DCTH stock.

Hundreds of people in England with a rare form of cancer affecting the eye will ... 01-positive adults with unresectable or metastatic uveal melanoma (mUM) – changing its position after issuing ...

Uveal melanoma is the most common primary malignancy of the eye and frequently leads to metastatic death. Until the mid-20th Century, the only treatment for uveal melanoma was enucleation.

Researchers around the world are looking at better ways to diagnose and treat eye cancer. Go to Cancer Research UK’s ... of the targeted drug IDE196 (darovasertib) for metastatic uveal melanoma. In ...

Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in adults. Their goal is to use these models to better understand how this ...

Get Instant Summarized Text (Gist) Organoid models have been developed to study uveal melanoma, a common adult eye cancer, using patient-derived tissue to create accurate 3D models. These ...